Schering-Plough (SGP) CEO Hassan Buys $2M Worth of Stock
More News related to SGP
- FDA Says It Is Investigating Potential Link Between Vytorin and Risk of Cancer (MRK, SGP)
- Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
- Schering-Plough (SGP) Reports July Vytorin/Zetia Volume
- Gates' The Bill and Melinda Gates Foundation Shows New Positions in Crocs (CROX), Dick's (DKS) and Raised Stakes in McDonald's (MCD), FedEx (FDX) and AIG (AIG)
- Schering-Plough Expands Its Presence in China, Enters Next Stage of Development
Schering-Plough Corp. (NYSE: SGP) today announced that its Chairman and CEO, Fred Hassan, bought over $2 million of Schering-Plough common stock, or 110, 000 shares at an average purchase price of $18.26 per share.
Hassan said, "As I said when I announced my intention to purchase these shares in January, this investment in Schering-Plough reflects my long-term confidence in the company, its products -- including ZETIA and VYTORIN -- and our late- stage pipeline."
Schering-Plough Corporation discovers, develops, manufactures, and sells pharmaceuticals worldwide. [BCS]
Related Categories
Hot ListInsider Trades
Stocks Mentioned
+0.10Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
